Hotstocked Newsletters

Promoted Companies

PROMOTION HISTORY
SORT BY:

Endonovo Therapeutics, Inc. (ENDV)

Total paid for Promotions this month: $5,000
E-mails this Month: 3
Estimated Volume Generated: $0
Research Report on ENDV: Click to see
* The information presented is based on information for Oct , 2015
Bad Biotech Day Equals Do Over Huddle Up, Traders! So the biotechs fell about 4% today and Endonovo Therapeutics Inc. (ENDV) naturally felt the weakness. Looks like we were a day early. But I’m seeing biotech bouncing back in the post-market so we might get another shot at glory tomorrow morning IF you give ENDV a second chance. After all, ENDV was impressive today in the face of those ...read more
Promoter: Stock Commander Paying Party: Emerald Advisors
Stocks covered: Compensation: Avg $ Volume for Period:
ENDV $2,500 UNKNOWN
Max Profit: 0.00 % Gain at close: Pending
              ENDV On The Cusp Of Pre-clinical Testing In $24.5 Billion Liver Disease Market   Good Afternoon!   ENDV is a hot opportunity in a very developed and proven sector. I am talking about biotech, of course. In the last 10 years no other sector on Wall Street has been as consistent, or delivered as much gains.   Biotech has enjoyed year-to-year growth, outperforming ...read more
Promoter: Prepump Stocks Paying Party: Microcap Innovations
Stocks covered: Compensation: Avg $ Volume for Period:
ENDV $15,000 UNKNOWN
Max Profit: 0.00 % Gain at close: Pending
                ENDV On The Cusp Of Pre-clinical Testing In $24.5 Billion Liver Disease Market   Good Afternoon!   ENDV is a hot opportunity in a very developed and proven sector. I am talking about biotech, of course. In the last 10 years no other sector on Wall Street has been as consistent, or delivered as much gains.   Biotech has enjoyed ...read more
Promoter: BeatPennyStocks Paying Party: Microcap Innovations
Stocks covered: Compensation: Avg $ Volume for Period:
ENDV $15,000 UNKNOWN
Max Profit: 0.00 % Gain at close: Pending
                  ENDV On The Cusp Of Pre-clinical Testing In $24.5 Billion Liver Disease Market   Good Afternoon!   ENDV is a hot opportunity in a very developed and proven sector. I am talking about biotech, of course. In the last 10 years no other sector on Wall Street has been as consistent, or delivered as much gains.   Biotech has enjoyed year-to-year ...read more
Promoter: PennyStock Buzz Paying Party: Microcap Innovations
Stocks covered: Compensation: Avg $ Volume for Period:
ENDV $15,000 UNKNOWN
Max Profit: 0.00 % Gain at close: Pending
                      ENDV On The Cusp Of Pre-clinical Testing In $24.5 Billion Liver Disease Market   Good Afternoon!   ENDV is a hot opportunity in a very developed and proven sector. I am talking about biotech, of course. In the last 10 years no other sector on Wall Street has been as consistent, or delivered as much gains.   Biotech has enjoyed ...read more
Promoter: DAMN GOOD PENNY PICKS Paying Party: Microcap Innovations
Stocks covered: Compensation: Avg $ Volume for Period:
ENDV $15,000 UNKNOWN
Max Profit: 0.00 % Gain at close: Pending
                 ENDV On The Cusp Of Pre-clinical Testing In $24.5 Billion Liver Disease Market Good Afternoon!   ENDV is a hot opportunity in a very developed and proven sector. I am talking about biotech, of course. In the last 10 years no other sector on Wall Street has been as consistent, or delivered as much gains.   Biotech has enjoyed year-to-year growth, ...read more
Promoter: Penny Stock Newsletters Paying Party: Microcap Innovations
Stocks covered: Compensation: Avg $ Volume for Period:
ENDV $15,000 UNKNOWN
Max Profit: 0.00 % Gain at close: Pending
            ENDV On The Cusp Of Pre-clinical Testing In $24.5 Billion Liver Disease Market   Good Afternoon!   ENDV is a hot opportunity in a very developed and proven sector. I am talking about biotech, of course. In the last 10 years no other sector on Wall Street has been as consistent, or delivered as much gains.   Biotech has enjoyed year-to-year growth, outperforming every ...read more
Promoter: PENNY PICKS Paying Party: Microcap Innovations
Stocks covered: Compensation: Avg $ Volume for Period:
ENDV $15,000 UNKNOWN
Max Profit: 0.00 % Gain at close: Pending
  Get the Full Picture, View in a Browser Get New Picks Instantly. From Your Cell Phone Text the Word "TNBT" to 63566 Bounce Play For The Afternoon Endonovo Therapeutics, Inc. (symbol: ENDV) We've seen a good amount of momentum from ENDV this morning and as we head into the afternoon we're going to be focused on this for a bounce. Rumors are buzzing...just like our play last week...that we are just the tip of the iceberg ...read more
Promoter: TheNextBigTrade.com Paying Party: Emedia advisors
Stocks covered: Compensation: Avg $ Volume for Period:
ENDV $15,000 UNKNOWN
Max Profit: 1.66 % Gain at close: Pending
  Get the Full Picture, View in a Browser Get Penny Stock News, Articles, Picks & Alerts Instantly. From Your Cell Phone Text the Word "BDPS" to 82257 Bounce Play For The Afternoon Endonovo Therapeutics, Inc. (symbol: ENDV) We've seen a good amount of momentum from ENDV this morning and as we head into the afternoon we're going to be focused on this for a bounce. Rumors are buzzing...just like our play last week...that ...read more
Promoter: BestDamnPennyStocks.com Paying Party: EMedia Solutions
Stocks covered: Compensation: Avg $ Volume for Period:
ENDV $15,000 UNKNOWN
Max Profit: 1.66 % Gain at close: Pending
    Trouble viewing this email? Read it online       Get My Alerts Instantly. From Your Cell Phone Text the Word "Able" to 82257   Important Update... Endonovo Therapeutics, Inc. (symbol: ENDV)   Good Morning,   ENDV started the day up 3% on its previous close of .58. The .60 open was quickly followed by a surge in investor interest which pushed ...read more
Promoter: Able Traders Paying Party: Emerald Advisors
Stocks covered: Compensation: Avg $ Volume for Period:
ENDV $5,000 UNKNOWN
Max Profit: 0.00 % Gain at close: Pending
First  << >> Last